Open company graph database — free web & API
Login

Arinamin Pharmaceutical Co., Ltd.

アリナミン製薬株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
4
§01

Basic information

BASIC
Head office
23rd floor, Jōkō Building, 1-8-2 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan
Chief executive
Atsu Morizawa
Capital
50,000,000
Employees (non-consolidated)
Employees (consolidated)
Start date
2017-04-01
End date
2026-04-01
§02

Websites

1 DOMAINS
§03

Business

4
Manufacturing and sale of food and related productsPharmaceuticalsOver-the-counter drugsMedical devices
§04

Related companies

4 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Arinamin PharmaTech Co., Ltd.
Group
Social Welfare Corporation Yūkari
Group
合利他命藥品股份有限公司
Group
日本製薬株式会社
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

4 EVENTS

Date of establishment: April 1, 2017Sources

Through the transfer of shares to a private equity fund operated by The Blackstone Group Inc. and its affiliates, the capital relationship with Takeda Pharmaceutical Company Limited was dissolved, and the company was renamed Arinamin Pharmaceutical Co., Ltd. Consequently, Takeda Healthcare Co., Ltd. was renamed Arinamin Farmatech Co., Ltd.Sources

Acquisition of all shares of Yuuka Holdings Co., Ltd. (now Yuuka Co., Ltd.)Sources

Acquisition of all shares of Nihon Pharmaceutical Co., Ltd. The Blackstone Group Inc., which is 100% shareholder of our company, and its related funds entered into a share transfer agreement with MBK Partners, and the share transfer was completed within the year.Sources

§07

News

16 ARTICLES

Arinamin and Sanrio Characters CollaborationSources

Arinamin Pharmaceutical will launch the "Arinamin | Sanrio Characters" tie‑up campaign from November 1. "Pom Pom Purin", "Cinnamoroll", and "Pochacco" will appear in Arinamin‑exclusive support uniforms, and campaign‑exclusive prizes will be offered.

Haruka Ayase Appointed as Brand Messenger for Arinamin R Herbal PremiumSources

Arinamin Pharmaceutical has appointed Haruka Ayase as its brand messenger and began nationwide broadcast of its new TV commercial 'Birth! Golden Arinamin' from October 26. The TV commercial introduces the features of Arinamin R Herbal Premium and appeals to customers seeking energy and vitality.

Alinamin R Herbal Premium LaunchedSources

Alinamin Pharmaceutical Co., Ltd. launched Alinamin R Herbal Premium on October 26, 2026. The product contains six herbal ingredients, including astragalus and Siberian ginseng, and six vitamins. It is intended to help reduce fatigue accumulated in daily life and replenish energy and vitality, while supporting nourishment and recovery from fatigue.

VitaAge New Release – Countering Oxidative Stress Associated with AgingSources

Arinamin Pharmaceutical Co., Ltd. will launch the third-class drug 'VitaAge', a W antioxidant formulation, on October 28, 2026. Focusing on oxidative stress, the product contains vitamins E and C to address fatigue and increased reactive oxygen species associated with aging.

Ann Nakamura and the 'Three Good Things Biostree' Campaign LaunchSources

Alinamin Pharmaceutical launched the 'Three Good Things Biostree' campaign today with Ann Nakamura, advocating the importance of butyrate bacteria. The campaign introduced products such as Biostree Hi tablets and Biostree H, explaining the functions of butyrate bacteria, lactic acid bacteria, and glycating bacteria, as well as how to take them.

Ayase Haruka Appears in Her 15th Year of Benza Block DX TV CommercialsSources

A new TV commercial for the Benza Block Premium DX series began airing on Friday. It features Haruka Ayase, appearing in the campaign for the 15th year, alongside Daiki Sato, Genta Matsuda, Airi Suzuki, and Yui Sakurai. The commercial shows them quickly overcoming nasal, throat, fever, and cough symptoms, with their expressions of relief standing out.

Alinamin Pharmaceutical Publishes Study on Reducing Stress in Recreational RunnersSources

Alinamin Pharmaceutical published an article presenting research on reducing stress in runners. The study assessed the conditioning effects of a formulation containing fursultiamine and was published in an academic journal in August 2026.

New Launch: 'Euglena for Better Sleep Habits'Sources

'Euglena for Better Sleep Habits,' jointly developed by Alinamin Pharmaceutical and MatsukiyoCocokara, will launch as a food with function claims to improve sleep quality and ease fatigue and stress upon waking. It is scheduled to be sold at Matsumotokiyoshi Group stores nationwide and online.

Contraception Awareness and Reality SurveySources

Arinamin Pharmaceutical conducted a survey on contraception among 1,000 women aged 20-40. 30.8% of respondents experienced the possibility of an unwanted pregnancy due to contraceptive failure or not using contraception, and 75.0% of those partners were male. Additionally, 38.6% of respondents were anxious because they could not confirm whether their contraception had failed or succeeded.

Sleep Awareness Event on World Sleep Day Explains How We Fall AsleepSources

On September 3, World Sleep Day, Alinamin Pharmaceutical held an awareness event focused on falling asleep. Professor Masashi Yanagisawa explained the body clock and the mechanisms behind sleepiness. In a survey of 500 working adults aged 20 to 60 nationwide, about 60% said they had difficulty falling asleep at least once in the previous week. The results indicated that the importance of falling asleep is not yet widely recognized.

§08

Public records

GOV
National Tax Agency basic information1010003032757
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
アリナミン製薬株式会社
Trade name (kana)
アリナミンセイヤク
Name in English
Corporation type
301
Address
〒100-0005 東京都千代田区丸の内1丁目8番2号
Postal code
1000005
Prefecture code
13
City code
101
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2020-08-04
Update date
2024-07-23
Change date
2024-07-01
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
令和6年7月1日東京都千代田区丸の内一丁目8番2号アリナミン製薬株式会社(7010001211357)を合併
Latest record
1
Excluded from search
0
Processing type
71
Correction type
0
Trade name image ID
Address image ID
Sequence number
1289935
METI gBizINFO1010003032757
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
1010003032757
Trade name
アリナミン製薬株式会社
Trade name (kana)
アリナミンセイヤク
Trade name (alphabet)
Registry closure date
2026-04-01
Reason for registry closure
11
Registered address
東京都千代田区丸の内1丁目8番2号
Postal code
1000005
Prefecture
東京都
Prefecture code
13
City or district
千代田区
City code
101
Street address
丸の内1丁目8番2号
Organisation type
301
Processing type
21
Correction type
0
Status
閉鎖
Representative
代表取締役 森澤 篤
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
2020-07-30
Unified government qualification - grade
|A||
Unified government qualification - business items
222
Update date
2026-04-10
Key information
1010003032757
§09

Sources & updates

SOURCES
↑